Intractable & Rare Diseases Research
Online ISSN : 2186-361X
Print ISSN : 2186-3644
ISSN-L : 2186-3644

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Frontal fibrosing alopecia treatment options
Raymond FertigAntonella Tosti
著者情報
ジャーナル フリー 早期公開

論文ID: 2016.01065

この記事には本公開記事があります。
詳細
抄録

Frontal fibrosing alopecia (FFA) is a rare dermatologic disease that causes scarring and hair loss and is increasing in prevalence worldwide. FFA patients typically present with hair loss in the frontal scalp region and eyebrows which may be associated with sensations of itching or burning. FFA is a clinically distinct variant of lichen planopilaris (LPP) that affects predominantly postmenopausal women, although men and premenopausal women may also be affected. Early diagnosis and prompt treatment are necessary to prevent definitive scarring and permanent hair loss. Data from retrospective studies indicate that 5-alpha-reductase inhibitors (5aRIs) are effective in stabilizing the disease. In our clinical experience, we have seen optimal results treating FFA patients with oral finasteride in conjunction with hydroxychloroquine, topical calcineurin inhibitors (tacrolimus) and excimer laser in patients with signs of active inflammation.

著者関連情報
© 2016 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
feedback
Top